Miaomiao Gou

Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer

Miaomiao Gou, Tongtong Qu, Zhikuan Wang et al. · Journal of Immunology Research · 2021 · 56 citations · Full text

Medicine, Oncology, Pharmacology +17

LncRNA HEIH promotes cell proliferation, migration and invasion in cholangiocarcinoma by modulating miR-98-5p/HECTD4

Tao Wan, Hongguang Wang, Miaomiao Gou et al. · Biomedicine & Pharmacotherapy · 2020 · 52 citations · Full text

Medicine, Molecular Biology, Oncology +17

Fruquintinib in Combination With PD-1 Inhibitors in Patients With Refractory Non-MSI-H/pMMR Metastatic Colorectal Cancer: A Real-World Study in China

Miaomiao Gou, Niansong Qian, Yong Zhang et al. · Frontiers in Oncology · 2022 · 46 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

<p>Efficacy and safety of nivolumab for metastatic biliary tract cancer</p>

Miaomiao Gou, Yong Zhang, Haiyan Si et al. · OncoTargets and Therapy · 2019 · 37 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer

Jun Jia, Pengfei Zhang, Miaomiao Gou et al. · Disease Markers · 2019 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17